Educating a Global Bioprocessing Workforce
In a global healthcare crisis, shipping treatments around the world is not always enough. Instead, therapeutics need to be manufactured closer to the point of use, but that requires both hard and soft infrastructure.
The soft infrastructure is a trained workforce, which is crucial to successfully manufacturing vaccines and therapeutics. To support and encourage bioprocessing in more countries, the National Center for Therapeutics Manufacturing (NCTM), located at the Texas A&M Engineering Experiment Station at College Station, started training international groups of engineers, scientists, and technicians through its Advanced Certificate in Biopharmaceutical Manufacturing (ACBM) program.